Loading...

Major Indexes

Operating Data

Array BioPharma Inc.

Array BioPharma Inc. (ARRY)

$46.57
17.69 (+61.25%)

Operating Data

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 69.5842.0851.90137.87150.84173.75234.24315.77425.69573.88773.65
Revenue (%)
EBITDA -30.71-65.8612.79-74.31-92.54-121.44-140.99-190.06-256.23-345.42-465.66
EBITDA (%)
EBIT -39.54-75.623.29-82.21-102.07-129.93-168.77-227.51-306.71-413.48-557.41
EBIT (%)
Depreciation 8.829.779.507.909.538.5027.7837.4550.4968.0691.75
Depreciation (%)




EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT)
EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income)
EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization
EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company
(1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments),
(2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill)
(3*) collections of assets (by ignoring depreciation of assets)
(4*) different takeover histories (by ignoring amortization often stemming from goodwill)